Treatment of 30 Cases of Spontaneous Tumours in Dogs with Triethylene Glycol Diglycidyl Ether
1962

Treatment of Tumors in Dogs with Triethylene Glycol Diglycidyl Ether

Sample size: 30 publication Evidence: moderate

Author Information

Author(s): L. N. Owen

Primary Institution: Department of Veterinary Clinical Studies, School of Veterinary Medicine, Cambridge

Hypothesis

Can triethylene glycol diglycidyl ether effectively treat spontaneous tumors in dogs?

Conclusion

The treatment showed some regression of tumors in dogs, particularly in cases of tonsillar epithelioma and reticulum cell sarcoma, but also had significant toxic effects.

Supporting Evidence

  • Nine out of 22 dogs treated intravenously showed regression of tumors.
  • Two dogs with tonsillar epithelioma had significant improvement after treatment.
  • Three dogs treated intra-arterially showed good regression without early death.

Takeaway

This study tested a special medicine on sick dogs with tumors to see if it could help them feel better, and it worked a little for some dogs but also made them sick.

Methodology

Dogs with inoperable malignant tumors were treated with intravenous or intra-arterial injections of triethylene glycol diglycidyl ether.

Potential Biases

Potential bias due to lack of randomization and selection of cases based on owner cooperation.

Limitations

The study lacked a controlled design and had a small sample size, making it difficult to draw definitive conclusions.

Participant Demographics

Dogs aged between 6 and 15 years, with a majority being older and having inoperable tumors.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication